Lane Generational LLC Acquires Shares of 609,603 Cardlytics, Inc. (NASDAQ:CDLX)

Lane Generational LLC acquired a new stake in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 609,603 shares of the company's stock, valued at approximately $1,109,000. Cardlytics comprises approximately 1.2% of Lane Generational LLC's investment portfolio, making the stock its 23rd biggest position. Lane Generational LLC owned 1.17% of Cardlytics at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Intech Investment Management LLC grew its position in shares of Cardlytics by 31.3% in the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock worth $72,000 after buying an additional 4,607 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Cardlytics by 46.0% in the fourth quarter. Wells Fargo & Company MN now owns 21,106 shares of the company's stock valued at $78,000 after acquiring an additional 6,649 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Cardlytics by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,060,739 shares of the company's stock valued at $3,936,000 after acquiring an additional 7,561 shares in the last quarter. Two Sigma Investments LP boosted its holdings in Cardlytics by 12.5% in the fourth quarter. Two Sigma Investments LP now owns 94,901 shares of the company's stock valued at $352,000 after acquiring an additional 10,508 shares in the last quarter. Finally, Two Sigma Advisers LP boosted its holdings in Cardlytics by 44.1% in the fourth quarter. Two Sigma Advisers LP now owns 36,900 shares of the company's stock valued at $137,000 after acquiring an additional 11,300 shares in the last quarter. Institutional investors own 68.10% of the company's stock.

Cardlytics Stock Down 9.3%

Shares of NASDAQ:CDLX traded down $0.25 during trading on Friday, hitting $2.45. The stock had a trading volume of 1,384,642 shares, compared to its average volume of 2,138,374. Cardlytics, Inc. has a 12 month low of $1.22 and a 12 month high of $8.94. The company has a market capitalization of $128.63 million, a PE ratio of -0.69 and a beta of 1.21. The firm's fifty day moving average is $1.86 and its 200 day moving average is $2.20. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 2.62.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital cut their price target on shares of Cardlytics from $3.00 to $2.50 and set a "hold" rating on the stock in a report on Thursday, May 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Cardlytics presently has an average rating of "Hold" and a consensus target price of $3.50.

Cardlytics Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.